Berlin, Germany, June 3, 2016 / B3C newswire / -- BioGenes GmbH, a global leader in host cell protein (HCP) assay development, has entered into a collaboration with Eurofins BioPharma Product Testing Munich (Eurofins Munich), an internationally renowned …
Potsdam, Germany, June 3, 2016 / B3C newswire / -- The medical technology company Emperra was selected to participate in the German Accelerator Life Sciences (GALS) program. The initiative of the Federal Ministry for Economic Affairs and Energy supports …
Company also announces new ASCO data presentation from the prospective PROMIS study assessing the clinical impact of the definitive MammaPrint 70-gene assay results for patients previously classified as indeterminate by the 21-gene assay (OncotypeDx) …
Bispecific Cancer Antibody Pipeline Optimized by GlymaxX® Manufacturing Technology Berlin, Germany and Utrecht, The Netherlands, June 1, 2016 / B3C newswire / -- ProBioGen AG and Merus N.V. today jointly announced that Merus has signed a commercial multi …
Oss and Maastricht, The Netherlands, June 1, 2016 / B3C newswire / -- ChemConnection, a privately-held company manufacturing nanomedicines, bioconjugates, peptides, and small molecules, announces the successful GMP production of CriPec® docetaxel for its …
Study will evaluate preliminary safety and effectiveness in a cohort of up to 24 patients Innovative regenerative technology will use patients’ own skin cells to try to close chronic Diabetic Foot Ulcer (DFUs) DFUs represent a significant new potential …
Launch of first joint product – VEGF 165 for cell culture applications Vienna and Grambach/Graz, Austria, May 24, 2016 / B3C newswire / -- Evercyte GmbH, the leading provider of immortalized human primary-like cells and VTU Technology, the globally acting …
Afucosylation can enable more precise assessment of allergic sensitization Berlin and Freiburg, Germany, 18 May, 2016 / B3C newswire / -- ProBioGen, a leading specialist for contract development and manufacturing of complex glycoproteins and …
Late Breaking Oral Presentation (abstract #LBA4001) on June 6 at 8:12 AM Mainz, Germany, May 17, 2016 / B3C newswire / -- Ganymed Pharmaceuticals AG, a biopharmaceutical company developing highly targeted immunotherapies against cancer, announced today …
Leading CDMO claims prestigious customer award from one of the top-20 biopharmaceutical companies Ravensburg, Germany, May 11, 2016 / B3C newswire / -- AbbVie, one of the world’s leading biopharmaceutical companies has awarded Vetter, a leading contract …
Dortmund, Germany, May 11, 2016 / B3C newswire / -- The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH and Boehringer Ingelheim International GmbH have signed an agreement providing Boehringer Ingelheim with the option to receive the …
Garching, Germany, May 10, 2016 / B3C newswire / -- ITM Isotopen Technologien München AG, a specialized radiopharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), …
The $1.8 million U.S. National Cancer Institute (NCI) grant, awarded to the Medical University of South Carolina (MUSC), is intended to support a research program covering a variety of solid tumor cancers, including a Phase II study with YELIVA™ (ABC294640 …
Preliminary Data Shows That ISTH0036 was Safe and Well Tolerated at Therapeutic Dose Levels Munich, Germany, May 4, 2016 / B3C newswire / -- Isarna Therapeutics, the leader in transforming growth factor beta (TGF-ß) isoform targeted antisense therapeutics …
London, UK, May 3, 2016 / B3C newswire/ – ORCHARD THERAPEUTICS, a clinical-stage biotechnology company with operations in London and the United States, has officially launched today with a £21-million Series A financing led by F-Prime Capital. As part of …
BOTHELL, WA -- (Marketwired) -- 05/03/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases announced that they have terminated negotiations with Microlin Bio, Inc. for the …
NEW YORK, NY -- (Marketwired) -- 05/03/16 -- Sinequa today announced the general availability of Sinequa ES Version 10. Powered by Machine Learning capabilities at its core, this ground breaking version helps deliver deep analytics of contents and user …
SANTA ANA, CA -- (Marketwired) -- 05/03/16 -- ADVANTIS CORPORATION (OTC PINK: ADVT) announced it has hired Thomas Elgin, MD, as its Chief Medic. Dr. Elgin has worked in emergency medicine for fifteen years, and has extensive experience researching and …
SALT LAKE CITY, UT -- (Marketwired) -- 05/03/16 -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce it has reduced its total debt obligations to $12.9 …
BOTHELL, WA, and BAAR, SWITZERLAND -- (Marketwired) -- 05/03/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases and Turing Pharmaceuticals AG a privately-held …
04 days 11:00:23
